20.01.2016 • NewscompanyDede WillamsJohnson & Johnson

J&J to cut 3,000 jobs in Medical Devices

US healthcare giant Johnson & Johnson has announced it will eliminate about 3,000 jobs in its medical devices division, or about 4-6% of the unit’s global workforce. The move is expected to generate annual cost savings of $800 million to $1 billion and allow the company to focus on more innovative products. Most of the savings are expected by the end of 2018, including about $200 million in 2016.

The job cuts will affect J&J's orthopedics, surgery and cardiovascular operations, but the company told US news agencies it had no immediate plans to eliminate specific products. The consumer medical devices, vision care and diabetes care will not be affected, Sales of J&J's underperforming medical device division fell by around 10% to nearly $19 billion in the first three quarters of 2015, The company will report fourth quarter results next week.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.